What is Your Next Step?
A. Posterior lamellar resection of the eyelid B. Full-thickness resection of the eyelid with frozen section control C. Orbital exenteration D. Stereotactic radiotherapy.
Correct Answer: D.
Full-thickness resection of the eyelid with frozen section control of margins.
Findings
Following resection, histopathology revealed a mass arising from the conjunctiva with a moderately differentiated invasive carcinoma showing predominant squamous differentiation and keratinization [ Fig. 1c ]. Glandular areas with goblet cells [Fig. 1d , arrows] were identified within the tumor nests and were highlighted with PAS and Alcian blue stains. The squamous component of the lesion strongly expressed cytokeratin 17 (CK17), while the goblet cells and glandular component of the lesion expressed CK7. These findings were compatible with mucoepidermoid carcinoma, now referred to as adenosquamous carcinoma by the World Health Organization.
[1]
Diagnosis

Conjunctival adenosquamous carcinoma
Discussion
This malignancy demonstrated full-thickness eyelid invasion, so choice B, and not A, would be most appropriate. There was no evidence of orbital invasion, so choice C is not correct, and this mass was surgically resectable so choice D is not considered.
Conjunctival adenosquamous carcinoma is rare, accounting for <1% of all conjunctival tumors. [2] This malignancy develops in the conjunctiva as a gray-white mass, typically in older patients and with an aggressive course. Histopathologically, this tumor is characterized by epidermoid and mucin-producing malignant (goblet) cells. This carcinoma can demonstrate CK7 positivity (CK7+), typically lost in conventional conjunctival SCC that usually expresses only CK17. Rankin et al. emphasized that CK7+ staining in an epibulbar squamous dysplasia/carcinoma and coexistent intracellular mucin (highlighted with Alcian blue or mucicarmine stains) should raise consideration for adenosquamous carcinoma. [3] Wide surgical resection is advocated for management of this malignancy.
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